Atrium Therapeutics, Inc. (RNA) operating margin

Operating margin · fiscal 2025
-412.6%

Atrium Therapeutics, Inc. (RNA) had an operating margin of -412.6% in fiscal 2025 (the year ended December 31, 2025). That is 291.3 percentage points lower than the -121.3% of fiscal 2024. Figures as of 17 Nov 2026, 17:34 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2025
-412.6%
Change on fiscal 2024
−291.3 pts
Highest on record
-65.4%fiscal 2023
Lowest on record
-2769.9%fiscal 2018
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Atrium Therapeutics, Inc. operating margin, in more detail

Across the 8 fiscal years on record (2018–2025), the highest was -65.4% in fiscal 2023 and the lowest -2769.9% in fiscal 2018. The fiscal 2025 figure is higher than in 71% of the 7 earlier fiscal years on record, whose median is -747.4%.

Net margin was -411.9% in fiscal 2025.

History · 8 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Net margin

Atrium Therapeutics, Inc. operating margin, year by year

Atrium Therapeutics, Inc. (RNA) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedNet margin
2025-412.6% 291.3 pts down-411.9%
2024-121.3% 55.9 pts down-230.5%
2023-65.4% 1874.2 pts up-65.4%
2022-1939.6% 673.8 pts down-1886.3%
2021-1265.8% 613.4 pts down-1265.4%
2020-652.4% 95.0 pts up-653.5%
2019-747.4% 2022.5 pts up-1066.6%
2018-2769.9%—-2959.4%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

More on RNA

Atrium Therapeutics, Inc., figure by figure

Atrium Therapeutics, Inc. (RNA) overview: price, valuation and scorecard

Atrium Therapeutics, Inc. operating margin: questions and answers

What is Atrium Therapeutics, Inc.'s operating margin?

Atrium Therapeutics, Inc. (RNA) had an operating margin of -412.6% in fiscal 2025 (the year ended December 31, 2025). That is 291.3 percentage points lower than the -121.3% of fiscal 2024.

Is Atrium Therapeutics, Inc.'s operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in 71% of the 7 earlier fiscal years on record, whose median is -747.4%.

What are the highest and lowest operating margin figures on record for Atrium Therapeutics, Inc.?

Across the 8 fiscal years on record (2018–2025), the highest was -65.4% in fiscal 2023 and the lowest -2769.9% in fiscal 2018.

What are Atrium Therapeutics, Inc.'s gross and net margins?

Net margin was -411.9% in fiscal 2025.

How is Atrium Therapeutics, Inc.'s operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Atrium Therapeutics, Inc. (RNA) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/RNA/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.